Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0451641 (urolithiasis)
 3,973 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In a retrospective study of 120 patients with surgically proved primary hyperparathyroidism, 71 patients who were normotensive and 49 patients (41 percent) who were either hypertensive at the time of parathyroidectomy or had a history of hypertension were compared. The mean serum calcium levels in the normotensive and hypertensive patients were very similar (11.6 +/- 0.1 [SEM] mg/dl, and 11.8 +/- 0.1), ruling against the hypothesis that hypercalcemia per se is the dominant cause of the hypertension of hyperparathyroidism. The mean serum creatinine levels in the two groups were also very similar (1.02 +/- 0.05 and 1.09 +/- 0.05 mg/dl), indicating that the hypertension of hyperparathyroidism is not the consequence of advanced renal parenchymal damage. The hypertensive patients did not have a significantly higher prevalence of urolithiasis. A review of the data in this and related studies leads to the conclusion that the hypertension of hyperparathyroidism is heterogeneous in origin. The mean serum phosphate level in the hypertensive patients was significantly lower than that in the normotensive patients (2.20 +/- 0.06 mg/dl versus 2.69 +/- 0.09 mg/dl, p less than 0.02), which may be due to a decrease in renal tubular phosphate reabsorption secondary to hypertension.
 ...
PMID:Hypertension and hyperparathyroidism. Inverse relation of serum phosphate level and blood pressure. 685 80

The ratio of urinary calcium (UCa)/urinary creatinine (UCr) concentrations (mg/mg) during calcium loading has been used to diagnose hypercalciuric states in adults. The UCa/UCr ratios have been examined before and after an oral dose of calcium in 48 healthy children following five days of abstinence from dietary milk products. No differences in UCa/UCr ratios were observed between sexes, races, or age groups. UCa/UCr ratio before the calcium dose was 0.09 +/- 0.12 (mean +/- 2 SD) and increased to 0.12 +/- 0.15 in urine samples collected for four hours after the calcium load. A direct relationship between UCa/UCr ratio and urinary sodium (UNa)/UCr ratio was observed (r = .57, P less than .01). In six children, calcium loading studies were repeated without prior restriction of dietary calcium. Dietary calcium intake before the calcium loading had little effect upon UCa/UCr ratio before the calcium in these six children (0.068 vs 0.08); however, UCa/UCr values after the calcium load were significantly lower (0.08 vs 0.15) when no dietary calcium restriction preceded the calcium-loading study. These data may allow characterization of renal hypercalciuria and gastrointestinal hyperabsorption of calcium in children with urolithiasis.
 ...
PMID:Urinary excretion of calcium following an oral calcium loading test in healthy children. 707 15

The pathogenetic roles of idiopathic renal hypercalciuria and absorptive hypercalciuria in children with urolithiasis have not yet been determined. Oral calcium loading studies were performed in 21 children with unexplained calcareous urolithiasis. Thirteen children, aged 20 months to 17 years, were found to have renal hypercalciuria after an overnight fast (urinary calcium-urinary creatinine [UCa/UCr] ratio in milligrams, greater than 0.21). Four children were found to have absorptive hypercalciuria. In this group, fasting UCa/UCr values were normal (SEM, 0.12 +/- 0.02); however, UCa/UCr values were elevated (SEM, 0.31 +/- 0.01) after the oral calcium load. Serum parathyroid hormone values were normal in all children with hypercalciuria. Urinary calcium excretion was normal in four patients. These data indicate that hypercalciuria may frequently occur in children with urolithiasis and that detailed metabolic evaluation is warranted in children with kidney stone disease.
 ...
PMID:Hypercalciuria in children with urolithiasis. 710 17

Outpatient renal stone formers belonging to the established urolithiasis subgroups and controls were examined with respect to urinary and serum citrate (Cit) and several associated variables. Only in the normocalciuric majority of calcium and in uric acid stone formers was Cit in 24-hour urine decreased, but was normal in 2-hour fasting morning, and in 3-hour postprandial urine following a Cit-free test meal. Serum Cit was elevated in normocalciuria, renal and resorptive hypercalciuria. This Cit constellation was associated with either normal (absorptive, renal hypercalciuria) or low (normocalciuria, uric acid stone formers) parathyroid gland function as assessed by serum parathyroid hormone and nephrogenous urinary cyclic AMP, except in patients with primary hyperparathyroidism. In 2-hour morning urine the magnesium/creatinine ratio (normocalciuria) and ammonia excretion (uric acid stone formers) were decreased, while ammonia in 24-hour urine was low in all stone formers. It is suggested that Cit metabolism is altered in renal stone disease in general, and that in normocalciuria, stone inhibitors (Cit; magnesium) may be deficient.
 ...
PMID:Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic. 712 65

Fifteen patients with recurrent renal stone formation were treated with 400 mg magnesium oxide daily. Urine composition was analyzed before the start of treatment and after 6-12 months. The urinary excretion of magnesium before and during treatment was 321 +/- 120 (mean +/- SD) and 409 +/- 140 mmol per mol creatinine respectively, a difference that was not statistically significant. Urinary calcium increased from 473 +/- 186 to 662 +/- 213 mmol per mol creatinine (p less than 0.05). All patients who increased their excretion of magnesium also increased the urinary output of calcium and, as a result of this, the calcium/magnesium-quotients were unaffected by the treatment. No significant effect was observed on urine oxalate excretion. Serum concentrations of calcium, magnesium and urate all remained at the pre-treatment level. From the results obtained in this study, magnesium oxide in this dosage cannot be recommended for use in treatment of patients with urolithiasis.
 ...
PMID:Urine composition in patients with urolithiasis during treatment with magnesium oxide. 722 14

Urinary excretion of calcium, magnesium and oxalate was studied in 38 patients with urolithiasis on two different occasions, and there appeared to be a good correlation between the biochemical findings in the two samples. All values were expressed per mole of creatinine and it was furthermore demonstrated that the variation in creatinine excretion was considerably less than the variation in urine volume. The calcium/magnesium quotients were calculated in 113 2-hour fasting urine samples and 24-hour urine samples and a good correlation was obtained. Biochemical grouping of the patients was performed by means of the two sets of values and the result obtained was approximately the same in both cases.
 ...
PMID:Validity of biochemical findings in the evaluation of patients with urolithiasis. 735 65

Thirty-four male and seven female patients with urolithiasis were treated with 300 mg allopurinol daily for one year in order to prevent stone recurrences. The mean serum-urate concentration in all patients, and the urine urate excretion in patients with a pre-treatment urate excretion above 250 mmol per mol creatinine were significantly reduced. The mean urinary excretion of calcium, magnesium and oxalate was unaffected by the treatment, although six of eight patients with a pre-treatment oxalate excretion above 25 mmol per mol creatinine demonstrated lower urine oxalate values during the treatment. No significant differences were obtained concerning the calcium/magnesium or calcium x oxalate/magnesium x creatinine quotients, but lower values of the calcium x oxalate x urate/magnesium x creatinine2 quotient were observed during allopurinol administration.
 ...
PMID:Urine composition in patients with renal stone disease during treatment with allopurinol. 737 45

51 urologic patients were dialyzed following acute indications during 1968-77. The 47 adults were 31-81 (average 59) years old. Due to the frequency of occurrence the predominant diseases were: Urolithiasis (combined with pyonephrosis, urosepsis, nephrocirrhosis), malignant tumors, and bladder neck adenomas. 18 patients were postoperative cases. 32 patients suffered from severe diseases or complications outside the urogenital tract. According to a differentiation of three risk groups, there were 33 patients belonging to the most severe group III. The patients' admission to the dialysis unit was late in most cases: 13 patients were already in coma or precoma, 18 patients overhydrated, 11 patients' serum potassium was more than 7 mval/1,28 patients' serum creatinine was more than 10 mg/dl. A prophylactic dialysis was possible in 11 cases only. We have accepted all 51 acute urologic patients, admitted to our clinic, for dialysis treatment. Peritoneal dialysis was performed in all 51 patients, only in 6 of them this treatment was followed by haemodialyses. The reasons for prefering peritoneal dialysis were haemorrhages or the danger of haemorrhages, a critical cardiovascular state, or an extreme acotaemia. In 143 peritoneal dialyses with 91 insertions of stilet catheters, one perforation of the small intestine occurred. The patient survived the resulting peritonitis. 13 of 15 patients with this indication got into an operable state in the course of dialysis treatment. Lethality of 61 per cent (31 of the 51 patients died) was related to the severity of the basic urologic disease. 4 of these latter patients could have been admitted to a regular dialysis treatment. In further 6 cases this would have been possible after a special urologic treatment.
 ...
PMID:[Acute dialysis treatment of urologic patients]. 739 91

Twelve male patients with urolithiasis were treated with 300 mg allopurinol daily. Urinary urate decreased from 251 +/- 55 to 156 +/- 19 (mean +/- SD) mmol per mol creatinine. The inhibition of calcium oxalate crystal growth was measured in an in vitro system and the inhibition index increased from 0.51 +/- 0.06 to 0.57 +/- 0.08 (mean +/- SD). Urinary citrate excretion was unaffected by the treatment.
 ...
PMID:Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol. 742 78

Urine activity product ratios of uric acid, sodium urate, and ammonium urate and urinary excretion of metabolites were determined in 24-hour samples produced by 6 healthy Beagles during periods of consumption of a low-protein, casein-based diet (diet A) and a high-protein, meat-based diet (diet B). Comparison of effects of diet A with those of diet B revealed: significantly lower activity product ratios of uric acid (P = 0.025), sodium urate (P = 0.045), and ammonium urate (P = 0.0045); significantly lower 24-hour urinary excretion of uric acid (P = 0.002), ammonia (P = 0.0002), sodium (P = 0.01), calcium (P = 0.005), phosphorus (P = 0.0003), magnesium (P = 0.01), and oxalic acid (P = 0.004); significantly (P = 0.0001) higher 24-hour urine pH; and significantly (P = 0.01) lower endogenous creatinine clearance. These results suggest that consumption of diet A minimizes changes in urine that predispose dogs to uric acid, sodium urate, and ammonium urate urolithiasis.
 ...
PMID:Diet effect on activity product ratios of uric acid, sodium urate, and ammonium urate in urine formed by healthy beagles. 777


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>